Crosstalk between peroxisome proliferator-activated receptor-gamma and angiotensin II in renal tubular epithelial cells in IgA nephropathy
Our recent study suggested that peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist attenuates inflammatory response in activated tubular epithelial cells in IgA nephropathy (IgAN). Here, we explore thiazolidinediones as new therapeutic additives to established treatment regime of...
Description complète
Détails bibliographiques
| Publié dans: | Clinical immunology (Orlando, Fla.). - 1999. - 132(2009), 2 vom: 17. Aug., Seite 266-76
|
| Auteur principal: |
Xiao, Jing
(Auteur) |
| Autres auteurs: |
Leung, Joseph C K,
Chan, Loretta Y Y,
Tang, Sydney C W,
Lai, Kar Neng |
| Format: | Article en ligne
|
| Langue: | English |
| Publié: |
2009
|
| Accès à la collection: | Clinical immunology (Orlando, Fla.)
|
| Sujets: | Journal Article
Research Support, Non-U.S. Gov't
2-chloro-5-nitrobenzanilide
Angiotensin II Type 1 Receptor Blockers
Anilides
Culture Media, Conditioned
Immunoglobulin A
Interleukin-6
NF-kappa B
PPAR gamma
plus...
Receptor, Angiotensin, Type 1
Thiazolidinediones
Rosiglitazone
05V02F2KDG
Intercellular Adhesion Molecule-1
126547-89-5
Extracellular Signal-Regulated MAP Kinases
EC 2.7.11.24
Losartan
JMS50MPO89 |